Friday, 6 December 2019

Satellite Payloads Market Industry Outlook & Future Forecast Report Till 2025

The global satellite payload market is expected to reach USD 21.8 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 7.9%over the forecast period, owing to Increased government spending in space exploration activities is expected to boost the market growth over the forecast period. 

The growing popularity of communication and broadcasting services including pay TV and Over-The-Top (OTT) have led providers to develop advanced payload systems. Moreover, the increased penetration of payloads in the commercial sector is expected to propel the market demand.
The market is expected to witness significant growth as there has been a great rise in the ordering and manufacturing of vast constellations of satellites for earth observation and telecommunication. Incremental improvements in launch operations and vehicle design are enabling a reduction in time for the manufacturing of payloads. Moreover, the evolution of small satellites is leading to the production of smaller payloads to reduce launch costs.
The need for geospatial tracking and positioning in the commercial sector is expected to drive the demand for satellite payloads over the forecast period. The emergence of high throughput satellites has resulted in high data-rate satellite transmission capability, which in turn is creating new opportunities for enhanced applications such as military, navigation, and commercial.
Access Research Report of Satellite Payloads Market@ http://www.grandviewresearch.com/industry-analysis/satellite-payloads-market

Further key findings from the report suggest:
·       The remote sensing segment is expected to grow at a CAGR of over 8.0% over the forecast period as it is expected to emerge as a viable platform in the agriculture and mining sectors
·       The Low Earth Orbit (LEO) segment is expected to be the fastest-growing segment; this growth can be attributed to its increased demand in earth observation and imaging applications
·       The commercial segment is expected to grow at the fastest CAGR of over 9% from 2017 to 2025. Growing advancements including channelization, space-based inflatable reflector antenna, multi-beam antenna, and internet routers are expected to propel the demand for commercial satellite payloads.
·       The Asia Pacific satellite payload market is expected to account for a revenue share of over 30% by 2025, with the increase in the number of satellite launches and government spending in space research contributing to the regional demand
·       The key players in the industry include Airbus S.A.S., Harris Corporation, Lockheed Martin Corporation, Honeywell International Inc., and The Boeing Company
Grand View Research has segmented the satellite payload market by orbit, application, end-use, and region.
Satellite Payload Orbit Outlook (Revenue, USD Billion; 2014 - 2025)
·         Low Earth Orbit (LEO)
·         Medium Earth Orbit (MEO)
·         Geostationary Earth Orbit (GEO)
Satellite Payload Application Outlook (Revenue, USD Billion; 2014 - 2025)
·         Communication & Navigation
·         Remote Sensing
·         Surveillance
·         Others
Satellite Payload End-Use Outlook (Revenue, USD Billion; 2014 - 2025)
·         Civil
·         Military
·         Commercial
Satellite Payload Regional Outlook (Revenue, USD Billion; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    India
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Thursday, 5 December 2019

Nurse Call System Market Progressing At A CAGR Of 9.9% From 2019 To 2026


The Report Nurse Call System Market Size, Share & Trends Analysis Report By Technology (Wired Communication Equipment, Wireless Communication Equipment), By End Use, And Segment Forecasts, 2019 – 2026

The global nurse call system market size is expected to reach USD 2.38 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.9% during the forecast period. Increasing support for digital healthcare, government penalties for hospital readmissions, and demand for resident and patient safety are expected to drive the demand.

In addition, continuous technology advancements to bring in a new level of communication enabling the widest range of applications configuration to home cares, hospitals, or residential facilities are also expected to upsurge the demand for nurse call system. In April 2015, Mircom launched MiCare wireless nurse call system, designed to enable its integration with cloud technology.
Hospitals have a major share of the nurse call system market owing to the patient flow and increasing chronic and emergency case patients. Moreover, researchers are filing patents for technologies that offer uninterrupted communication. In December 2018, Ascom Holdings AG has received the approval certificate from the U.S. Food and Drug Administration (FDA) as class II 510(k) for Digistat Smart Central software solution increasing the scope of the Ascom Healthcare to expand their presence in the U.S. hospitals.
North America was the largest regional market owing to the establishment of separate certification and coding system and introduction of new integrated solutions by key players. For instance, in October 2018, Tunstall Healthcare acquired Kanayo Software Inc., and EWII Telecare to expand its Connected Health solutions. The acquisition provided Tunstall with expertise in Software and App products in health and social care.
Access Research Report of Nurse Call System Market @ www.grandviewresearch.com/industry-analysis/nurse-call-system-equipments-industry

Further key findings from the report suggest:
·       Wired communication equipment led the market in 2018 owing to the early adoption of technology and continuous innovations such as integration Wi-Fi cordless telephone, IP DECT, and radio pocket pager for greater efficiency and safety
·       Asia Pacific is the fastest growing market owing to the huge population base, high technology adoption rate, and government funding for digital health. The demand for real-time nurse call systems is increasing owing to the need to offer better patient response time and avoiding patient falls
·       Market participants are constantly evolving the traditional systems and are incorporating newer techniques and devices. In January 2019, the Hill Rom launched its LINQ mobile application for an improvement in communication between the patient and caregiver formerly in U.S. and Canada with further expansion to Europe
·       Some key players in the nurse call system market include Hill-Rom Holding, Inc.; Tyco SimplexGrinnell; Ascom Holding; Honeywell International, Inc.; Rauland-Borg Corporation; TekTone Sound & Signal Mfg., Inc.; Stanley Healthcare; Azure Healthcare; West-Com Nurse Call Systems, Inc.; and Critical Alert Systems LLC.
Grand View Research has segmented the global nurse call system market on the basis of technology, end use, and regions:
Nurse Call System Technology Outlook (Revenue, USD Million, 2015 - 2026)
·         Wired Communication Equipment
·         Wireless Communication Equipment
Nurse Call System End Use Outlook (Revenue, USD Million, 2015 - 2026)
·         Hospitals and Clinics
·         Outpatient Departments (OPDs)
·         Assisted Living Facilities (ALFs)
·         Ambulatory Care Services
·         Skilled Nursing Facilities
Nurse Call System Regional Outlook (Revenue, USD Million, 2015 - 2026)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
·         Asia Pacific
o    Japan
o    China
o    India
o    Australia
o    South Korea
·         Latin America
o    Brazil
o    Mexico
o    Argentina
·         Middle East & Africa
o    South Africa
o    United Arab Emirates (UAE)
o    Saudi Arabia

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Metabolic Disorder Therapeutics Market Size, Share, Growth and Profitability Analysis Forecasts To 2025


The Report Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration, By Disease (Diabetes, Lysosomal Disorders), By Therapy Type, By Region, and Segment Forecasts, 2019 – 2025

The global Metabolic Disorder Therapeutics Market size is expected to reach USD 88.93 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a CAGR of 7.56% during the estimated period. Rising incidences of diabetes, obesity, and hypercholesterolemia are expected to drive the market growth. It is estimated that by 2040, about 1 person in 11 people worldwide is likely to suffer from one of the aforementioned diseases.

Researchers estimate that the prevalence of metabolic diseases like obesity and diabetes is expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin American countries. This, in turn, will help boost the overall market growth in the year to come. Furthermore, with better economic stability in developing countries, demand for novel therapeutics for one-time treatment has increased. This has made major companies in the global market to invest heavily in R&D to develop innovative therapy options. All these factors will contribute to the development of the market.

Access Research Report of Metabolic Disorder Therapeutics Market @ 

Further key findings from the study suggest:
·       Diabetes segment led the market in 2017, in terms of revenue generation,owing to higher prevalence and drug usage
·       Obesity segment is expected to register a CAGR of 9.27% over the forecast period owing to increasing prevalence as a result of sedentary lifestyle changes
·       Drug therapy was the most-preferred therapy due to its high reliability proven success and availability of various types of drugs to treat metabolic diseases
·       The segment is expected to maintain its dominance even during the forecast years due to the introduction of smart technology to deliver antidiabetic drug on a regulated basis
·       Key companies in this market are Novo Nordisk A/S;Sanofi S.A.; BoehringerIngelheim GmbH; Eli Lilly and Company; Merck KgaA; Amgen, Inc.; AstraZeneca PLC; Actelion Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.;Biocon Ltd.;BioMarinPharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla, Inc.; and CymaBay Therapeutics, Inc.
·       Most of these companies are focusing on strategies, such as collaborations, expansion of product portfolios, and M&A to maintain their industry position
·       Oral route of administration was the key revenue-generating segment in 2017owing to its benefits, such as high reliability and ease of administration
·       North America was the largest regional market in 2017 and will maintain the trend in future due to the presence of key companies and rising cases of diabetes and obesity
Grand View Research has segmented the global metabolic disorder therapeutics market on the basis of disease, therapy type, route of administration, and region:
Metabolic Disorder Therapeutics Disease Outlook (Revenue, USD Billion, 2014 - 2025)
·         Lysosomal Storage Diseases
o    Gaucher’s Disease
o    Metachromatic Leukodystrophy
o    Hurler - Scheie
o    Sanfilipo A
o    Others
·         Diabetes
·         Obesity
·         Inherited Metabolic Disorders
·         Hypercholesterolemia
Metabolic Disorder Therapy Type Outlook (Revenue, USD Billion, 2014 - 2025)
·         Enzyme Replacement Therapy
·         Cellular Transplantation
·         Small Molecule Based Therapy
·         Substrate Reduction Therapy
·         Gene Therapy
·         Drug Therapy
Metabolic Disorder Therapeutics Route of Administration Outlook (Revenue, USD Billion, 2014 - 2025)
·         Oral
·         Parenteral
·         Others
Metabolic Disorder Therapeutics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
·         Middle East & Africa
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...